8
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Competitive sport after SARS-CoV-2 infection in children

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          With the gradual resumption of sports activities after the lock-down period for coronavirus pandemic, a new problem is emerging: Allow all athletes to be able to return to compete after SARS-CoV-2 infection in total safety. Several protocols have been proposed for healed athletes but all of them have been formulated for the adult population. The aim of the present study is to evaluate the adequacy of Italian practical recommendations for return-to-paly, in order to exclude cardiorespiratory complications due to COVID-19 in children and adolescents.

          Methods

          Between April 2020 and January 2021 the Italian Sports Medical Federation formulated cardiorespiratory protocols to be applied to athletes recovered from SARS-CoV-2 infection. The protocols take into account the severity of the infection. Protocols include lung function tests, cardiopulmonary exercise test, echocardiographic evaluation, blood chemistry tests.

          Results

          From September 2020 to February 2021, 45 children and adolescents (aged from 9 to 18 years; male = 26) with previous SARS-CoV-2 infection were evaluated according to the protocols in force for adult. 55.5% of the subjects ( N = 25) reported an asymptomatic infection; 44.5% reported a mild symptomatic infection. Results of lung function test have exceeded the limit of 80% of the theoretical value in all patients. The cardiorespiratory capacity of all patients was within normal limits (average value of maximal oxigen uptake 41 ml/kg/min). No arrhythmic events or reduction in the ejection fraction were highlighted.

          Conclusion

          The data obtained showed that, in the pediatric population, mild coronavirus infection does not cause cardiorespiratory complications in the short and medium term. Return to play after Coronavirus infection seems to be safe but it will be necessary to continue with the data analysis in order to modulate and optimize the protocols especially in the pediatric field.

          Related collections

          Most cited references2

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Case report and systematic review suggest that children may experience similar long‐term effects to adults after clinical COVID‐19

          Abstract Aim Persistent symptoms in adults after COVID‐19 are emerging and the term long COVID is increasingly appearing in the literature. However, paediatric data are scarce. Methods This paper contains a case report of five Swedish children and the long‐term symptoms reported by their parents. It also includes a systematic literature review of the MEDLINE, EMBASE and Web of Science databases and the medRxiv/bioRxiv pre‐print servers up to 2 November 2020. Results The five children with potential long COVID had a median age of 12 years (range 9–15) and four were girls. They had symptoms for 6–8 months after their clinical diagnoses of COVID‐19. None were hospitalised at diagnosis, but one was later admitted for peri‐myocarditis. All five children had fatigue, dyspnoea, heart palpitations or chest pain, and four had headaches, difficulties concentrating, muscle weakness, dizziness and sore throats. Some had improved after 6–8 months, but they all suffered from fatigue and none had fully returned to school. The systematic review identified 179 publications and 19 of these were deemed relevant and read in detail. None contained any information on long COVID in children. Conclusion Children may experience similar long COVID symptoms to adults and females may be more affected.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The incidence of the novel coronavirus SARS-CoV-2 among asymptomatic patients: a systematic review

            Highlights • The true incidence of SARS-COV-2 is much higher than the reported number of cases. • Large sample size studies showed 1.2-12.9% incidence of SARS-COV-2 among asymptomatics. • Studies with a small sample size showed up to 87.9% incidence among asymptomatics. • Asymptomatic individuals could be a potential source of infection to the community.
              Bookmark

              Author and article information

              Contributors
              giulia.cafiero@gmail.com , giulia.cafiero@opbg.net
              flaminia.passi@opbg.net
              fippolita.calo@opbg.net
              federica.gentili@opbg.net
              ugo.giordano@opbg.net
              chiara.pierri@opbg.net
              melania.hashemsaid@opbg.net
              attilio.turchetta@opbg.net
              Journal
              Ital J Pediatr
              Ital J Pediatr
              Italian Journal of Pediatrics
              BioMed Central (London )
              1824-7288
              6 November 2021
              6 November 2021
              2021
              : 47
              : 221
              Affiliations
              [1 ]GRID grid.414125.7, ISNI 0000 0001 0727 6809, Department of Cardiac Surgery, Cardiology and Heart Lung Transplant, Bambino Gesù Children’s Hospital, IRCCS, ; L.go S. Onofrio 4, 00165 Rome, Italy
              [2 ]GRID grid.414125.7, ISNI 0000 0001 0727 6809, Academic Pediatric Department, Immunological and Infectious Disease Unit, Bambino Gesù Children’s Hospital, IRCCS, ; Rome, Italy
              Article
              1166
              10.1186/s13052-021-01166-6
              8572058
              34742330
              3a07439e-de36-4872-8b93-7180ca948b2b
              © The Author(s) 2021

              Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

              History
              : 21 June 2021
              : 11 October 2021
              Categories
              Research
              Custom metadata
              © The Author(s) 2021

              Pediatrics
              sars-cov-2,cardiorespiratory assessment,children
              Pediatrics
              sars-cov-2, cardiorespiratory assessment, children

              Comments

              Comment on this article